AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32680441 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 37
Study 33742204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon watching
Number of subjects: 99
Study 33742204 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction card
Number of subjects: 99
Study 33742204 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study 32526448 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil count in overweight individuals
Number of subjects: 119
Study 32526448 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil count in moderately obese individuals
Number of subjects: 119
Study 32526448 — intervention group
Group type: COMPARATOR
Intervention: Blood markers (MADRS, CGI, ODQ)
Number of subjects: 119
Study 35715786 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 text messages during eight weeks (three text messages per week)
Number of subjects: 82
Study 35715786 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 82
Study 33012059 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐B Nestnet model
Number of subjects: 94
Study 33012059 — intervention group
Group type: COMPARATOR
Intervention: Original Unet model
Number of subjects: 94
Study 36036067 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation for 8 weeks
Number of subjects: 45
Study 36036067 — intervention group
Group type: COMPARATOR
Intervention: Routine outpatient treatment
Number of subjects: 45
Study 33509164 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous perineal electrostimulation
Number of subjects: 70
Study 33509164 — intervention group
Group type: COMPARATOR
Intervention: Intracavitary anal electrostimulation
Number of subjects: 70
Study 33238931 — intervention group
Group type: EXPERIMENTAL
Intervention: WiseApp intervention
Number of subjects: 200
Study 33238931 — intervention group
Group type: COMPARATOR
Intervention: Control group (walk step reminders, videos, and surveys focused on overall wellness)
Number of subjects: 200
Study 34473750 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counselling
Number of subjects: 588
Study 34473750 — intervention group
Group type: COMPARATOR
Intervention: Routine counselling (standard of care)
Number of subjects: 588
Study 32182586 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard warm-up (10 min at 60% of VO2peak)
Number of subjects: 15
Study 32182586 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP warm-up (5 min at 60% of VO2peak followed by three 10-s all-out sprints)
Number of subjects: 15
Study 32182586 — intervention group
Group type: COMPARATOR
Intervention: No warm-up
Number of subjects: 15
Study 33074892 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Surgical Safety Checklist
Number of subjects: 3702
Study 32847946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal low-dose dexmedetomidine (DEX); n=50
Number of subjects: 100
Study 32847946 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA); n=50
Number of subjects: 100
Study 35776029 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine-neostigmine (20 mcg/kg - 50 mcg/kg)
Number of subjects: 60
Study 35776029 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg)
Number of subjects: 60
Study 33388382 — intervention group
Group type: EXPERIMENTAL
Intervention: Netupitant/palonosetron (NEPA)
Number of subjects: 53
Study 33388382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 35218286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP)
Number of subjects: 20
Study 32580620 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (1200 mg) + weight loss regime
Number of subjects: 0
Study 32580620 — intervention group
Group type: EXPERIMENTAL
Intervention: Faradic (three 1 hour sessions) + weight loss regime
Number of subjects: 0
Study 32580620 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (1200 mg) + Faradic (three 1 hour sessions) + weight loss regime
Number of subjects: 0
Study 32580620 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1200 mg) + weight loss regime
Number of subjects: 0
Study 33297766 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior knot position
Number of subjects: 216
Study 33297766 — intervention group
Group type: COMPARATOR
Intervention: Anterior knot position
Number of subjects: 216
Study 33631337 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative calcium and calcitriol supplementation (calcitriol 0.25 μg po bid and calcium carbonate 1,500 mg po tid 5 days preoperatively and continued postoperatively)
Number of subjects: 82
Study 33631337 — intervention group
Group type: COMPARATOR
Intervention: Postoperative calcium and calcitriol supplementation (started postoperatively)
Number of subjects: 82
Study 33631337 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative calcium and calcitriol supplementation
Number of subjects: 82
Study 33631337 — intervention group
Group type: COMPARATOR
Intervention: Postoperative calcium and calcitriol supplementation
Number of subjects: 82
Study 34002565 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-separated moxibustion on segmental conception vessel combined with low-frequency TEAS (2 Hz, 10-15 mA, once every 2 days for 30 min, moxibustion once every 10 days for 3 months)
Number of subjects: 105
Study 34002565 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency TEAS (2 Hz, 10-15 mA, once every 2 days for 30 min)
Number of subjects: 105
Study 34002565 — intervention group
Group type: COMPARATOR
Intervention: Medication group (vitamin E capsules, coenzyme Q10 capsules, Wuzi Yanzong pills)
Number of subjects: 105
Study 35288439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 144
Study 35288439 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 144
Study 34706555 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (4 g daily)
Number of subjects: 8179
Study 34706555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study 32692994 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood arsenic level (measured in μg/L)
Number of subjects: 0
Study 32692994 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood arsenic levels above 3.69 μg/L (Log As ≥0.57)
Number of subjects: 0
Study 32692994 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood arsenic levels in smokers (≥15 years)
Number of subjects: 0
Study 32692994 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood arsenic levels less than 3.69 μg/L
Number of subjects: 0
Study 35758289 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbuthylazine + glyphosate
Number of subjects: 10
Study 35758289 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrazine + glyphosate
Number of subjects: 10
Study 35758289 — intervention group
Group type: EXPERIMENTAL
Intervention: [Atrazine + mesotrione] + glyphosate
Number of subjects: 10
Study 35758289 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated glyphosate
Number of subjects: 10
Study 35758289 — intervention group
Group type: COMPARATOR
Intervention: Nontreated control
Number of subjects: 10
Study 33535835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluzoparib (120 mg) under fed conditions
Number of subjects: 16
Study 33535835 — intervention group
Group type: COMPARATOR
Intervention: Fluzoparib (120 mg) under fasted conditions
Number of subjects: 16
Study 35093205 — intervention group
Group type: EXPERIMENTAL
Intervention: hIVIG
Number of subjects: 593
Study 33166271 — intervention group
Group type: EXPERIMENTAL
Intervention: Registry-based clinical trials for ACC
Number of subjects: 0
Study 33166271 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized registry-based trials in an adjuvant setting and for advanced disease
Number of subjects: 0
Study 35488667 — intervention group
Group type: EXPERIMENTAL
Intervention: IONM group
Number of subjects: 120
Study 35488667 — intervention group
Group type: COMPARATOR
Intervention: non-IONM group
Number of subjects: 120
Study 34089936 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-hour fasting treatment in 35 six-month-old laying pigeons, divided into 7 groups by different DELCs.
Number of subjects: 70
Study 34089936 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified).
Number of subjects: 70
Study 33515281 — intervention group
Group type: COMPARATOR
Intervention: Plasma oxalate (Pox) levels
Number of subjects: 106
Study 32410362 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methotrexate (MTX)
Number of subjects: 42
Study 32410362 — intervention group
Group type: EXPERIMENTAL
Intervention: OMP dexamethasone
Number of subjects: 42
Study 32410362 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral MTX and OMP dexamethasone
Number of subjects: 42
Study 32410362 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 33904625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g CG per day
Number of subjects: 40
Study 33904625 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g CG per day
Number of subjects: 40
Study 33904625 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g CG per day
Number of subjects: 40
Study 33904625 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g CG per day
Number of subjects: 40
Study 33904625 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary CG
Number of subjects: 40
Study 33904625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CG)
Number of subjects: 40
Study 32289723 — intervention group
Group type: EXPERIMENTAL
Intervention: rotational field TMS (rfTMS)
Number of subjects: 8
Study 32289723 — intervention group
Group type: COMPARATOR
Intervention: conventional unidirectional TMS (udTMS)
Number of subjects: 8
Study 34625316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (received the core and up to 4 custom elements of treatment, wrote what each image displayed)
Number of subjects: 0
Study 34625316 — intervention group
Group type: COMPARATOR
Intervention: Group B (presentation of the 18 elements with core elements chunked at the end followed by up to 4 custom elements)
Number of subjects: 0
Study 33635325 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (cognitive behavioral therapy and care management delivered mostly through telehealth for 6 months)
Number of subjects: 200
Study 33635325 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 200
Study 33635325 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 32969686 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor and Accept (MA) training, an 8-week mindfulness-based stress reduction (MBSR) intervention
Number of subjects: 0
Study 32969686 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor Only (MO) training, a modified 8-week MBSR-adapted intervention
Number of subjects: 0
Study 32969686 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT) control
Number of subjects: 0
Study 36052772 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus pemetrexed and carboplatin or cisplatin (APP)
Number of subjects: 163
Study 36052772 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed plus carboplatin or cisplatin (PP)
Number of subjects: 163
Study 34063790 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A deficiency (VAD) prevalence in Non-Hispanic Black and Hispanic pregnant women
Number of subjects: 0
Study 34063790 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele frequencies of vitamin A-related SNPs
Number of subjects: 0
Study 34063790 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor allele frequencies of SNPs associated with vitamin A metabolism
Number of subjects: 0
Study 32305099 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin-bevacizumab (experimental group)
Number of subjects: 682
Study 32305099 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-gemcitabine-bevacizumab (standard group)
Number of subjects: 682
Study 35568683 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C 190-219 mg/dL
Number of subjects: 5786
Study 35568683 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C 220-249 mg/dL
Number of subjects: 5786
Study 35568683 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C 250-299 mg/dL
Number of subjects: 5786
Study 35568683 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C ≥300 mg/dL
Number of subjects: 5786
Study 36264432 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigator program (immediate intervention group)
Number of subjects: 162
Study 36264432 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 162
Study 33900801 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopefulness
Number of subjects: 226
Study 33900801 — intervention group
Group type: EXPERIMENTAL
Intervention: Work stress
Number of subjects: 226
Study 33900801 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 226
Study 32448790 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10)
Number of subjects: 270
Study 32448790 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 270
Study 32448790 — intervention group
Group type: COMPARATOR
Intervention: PHiD-CV10 and PCV13
Number of subjects: 270
Study 32205331 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-tied non-adhesive tape (PT)
Number of subjects: 300
Study 32205331 — intervention group
Group type: EXPERIMENTAL
Intervention: Thomas Tube Holder (TH)
Number of subjects: 300
Study 32205331 — intervention group
Group type: COMPARATOR
Intervention: Gauze roll (GR)
Number of subjects: 300
Study 32921665 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 24
Study 32921665 — intervention group
Group type: COMPARATOR
Intervention: Febuxostat
Number of subjects: 24
Study 35215537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet (GI < 35, n = 17)
Number of subjects: 35
Study 35215537 — intervention group
Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) diet (GI > 70, n = 18)
Number of subjects: 35
Study 35215537 — intervention group
Group type: COMPARATOR
Intervention: Control diet (GI = 55–58)
Number of subjects: 35
Study 34510154 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyesi Indirect Ophthalmoscope simulator
Number of subjects: 0
Study 34510154 — intervention group
Group type: COMPARATOR
Intervention: Peer practice
Number of subjects: 0
Study 35488859 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus administration of FDG
Number of subjects: 15
Study 35488859 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant infusion of FDG
Number of subjects: 15
Study 35488859 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid bolus/infusion of FDG
Number of subjects: 15
Study 32277105 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 vaccination
Number of subjects: 0
Study 32277105 — intervention group
Group type: EXPERIMENTAL
Intervention: Having siblings
Number of subjects: 0
Study 32277105 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 0
Study 32277105 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying any pneumococcal serotype
Number of subjects: 0
Study 34176407 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib therapy
Number of subjects: 0
Study 32058845 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-WBRT plus memantine
Number of subjects: 518
Study 32058845 — intervention group
Group type: COMPARATOR
Intervention: WBRT plus memantine
Number of subjects: 518
Study 35917647 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed-platinum
Number of subjects: 397
Study 35917647 — intervention group
Group type: COMPARATOR
Intervention: placebo + pemetrexed-platinum
Number of subjects: 397
Study 35917647 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed-platinum (after adjusting for crossover)
Number of subjects: 397
Study 32194252 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home, nurse practitioner-led care management team
Number of subjects: 0
Study 32194252 — intervention group
Group type: COMPARATOR
Intervention: Telephonic care management program
Number of subjects: 0
Study 36610544 — intervention group
Group type: EXPERIMENTAL
Intervention: Deg-100
Number of subjects: 260
Study 36610544 — intervention group
Group type: COMPARATOR
Intervention: Gla-300
Number of subjects: 260
Study 34197452 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical and healthy lifestyle interventions
Number of subjects: 31326
Study 34197452 — intervention group
Group type: COMPARATOR
Intervention: Usual hypertension and diabetes care (Control)
Number of subjects: 31326
Study 33136059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for patients (educational group program, monitoring via logs, web-based platform, automated SMS)
Number of subjects: 2334
Study 33136059 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (for both patients and professionals)
Number of subjects: 2334
Study 33136059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for professionals (educational program, decision support tool, periodic feedback)
Number of subjects: 2334
Study 33136059 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2334
Study 33749970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean Body Mass (LBM) dosing
Number of subjects: 19
Study 33749970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal Body Weight (IBW) dosing
Number of subjects: 19
Study 33749970 — intervention group
Group type: COMPARATOR
Intervention: Total Body Weight (TBW) dosing
Number of subjects: 19
Study 32093557 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic passive peritoneal drain
Number of subjects: 25
Study 32093557 — intervention group
Group type: COMPARATOR
Intervention: Control (no peritoneal drain)
Number of subjects: 25
Study 32093557 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic passive peritoneal drain and Control
Number of subjects: 25
Study 35527578 — intervention group
Group type: EXPERIMENTAL
Intervention: AMT‐EST (Ankle Movement Training with Electrical Stimulation)
Number of subjects: 35
Study 35527578 — intervention group
Group type: COMPARATOR
Intervention: EST (Electrical Stimulation)
Number of subjects: 35
Study 33907267 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% Diquafosol (DQS) used six times daily after cataract surgery
Number of subjects: 0
Study 33907267 — intervention group
Group type: COMPARATOR
Intervention: 0.1% Sodium Hyaluronate (HA) used six times daily after cataract surgery
Number of subjects: 0
Study 33492667 — intervention group
Group type: EXPERIMENTAL
Intervention: Eclampsia
Number of subjects: 153
Study 33492667 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia complicated by pulmonary edema
Number of subjects: 153
Study 33492667 — intervention group
Group type: COMPARATOR
Intervention: Normotensive pregnancies
Number of subjects: 153
Study 33492667 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia without severe features
Number of subjects: 153
Study 616703485 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-Track (FT) protocol
Number of subjects: 63
Study 616703485 — intervention group
Group type: COMPARATOR
Intervention: Conventional (CON) protocol
Number of subjects: 63
Study 36058007 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of ginger extract daily for 3 months
Number of subjects: 66
Study 36058007 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 66
Study 33829804 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect intervention
Number of subjects: 97
Study 33829804 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study 32896390 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg daily)
Number of subjects: 915
Study 32896390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 915
Study 36192779 — intervention group
Group type: EXPERIMENTAL
Intervention: EMA plus visualization platform for 7 days
Number of subjects: 50
Study 36192779 — intervention group
Group type: COMPARATOR
Intervention: EMA alone for 7 days
Number of subjects: 50
Study 33764282 — intervention group
Group type: EXPERIMENTAL
Intervention: IDD group
Number of subjects: 6
Study 33142495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 2,760 IU/kg
Number of subjects: 390
Study 33142495 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 at 5,520 IU/kg
Number of subjects: 390
Study 33142495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 2,760 IU/kg plus 25OHD at 2,760 IU (69 μg)/kg
Number of subjects: 390
Study 33142495 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD
Number of subjects: 390
Study 35380078 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous siponimod 2 mg/day
Number of subjects: 0
Study 35380078 — intervention group
Group type: COMPARATOR
Intervention: Placebo-siponimod group
Number of subjects: 0
Study 34755994 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of normal saline 0.9% as irrigation solution (Group A)
Number of subjects: 330
Study 34755994 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml of normal saline 0.9% as irrigation solution (Group B)
Number of subjects: 330
Study 34755994 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 ml of normal saline 0.9% as irrigation solution (Group C)
Number of subjects: 330
Study 34755994 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 330
Study 32243029 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Belief Model based nursing interventions offered at home visits
Number of subjects: 72
Study 32243029 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 72
Study 34499002 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver nitrate application
Number of subjects: 155
Study 34499002 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone stent insertion
Number of subjects: 155
Study 34499002 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 155
Study 34618202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg/24 h)
Number of subjects: 72